Skip to main content
News Icon

News categories: Honors & Funding

New ImmunoSensation² research group

We introduce: Prof. Özgün Gökce

Neurobiologist Özgün Gökce was recently recruited to the German Center of Neurodegenerative Diseasses (DZNE) on campus of at the University Hospital Bonn. He is also a member of the Medical Faculty at Bonn University. As head of the research group "Systems Neuroscience – Cell Diversity", Gökce has been appointed as a member of ImmunoSensation2 from March 2023.

As an interdisciplinary neuroscientist, Özgün Gökce develops novel approaches to study nervous system for preserving cognitive health during aging and thwarting neurodegeneration. In a period of rapid and transformative technological breakthroughs, he and his team aim to develop and employ innovative tools to unravel the core principles governing the nervous system in both healthy and diseased states.

"Our research group represents a synergistic fusion of multi disciplinary expertise, striving to unravel the complexities of age-related brain disorders through the development of cutting-edge quantitative genomics techniques." Gökce says. "Our mission is to decode the cellular responses underlying the aging process and to dissect the molecular mechanisms driving neurodevelopmental and neurodegenerative disorders." To achieve these objectives, his team develops and integrates state-of-the-art technologies, including single-cell RNA sequencing (scRNA-seq), spatial transcriptomics (ST), electron microscopy, and machine learning algorithms, forging a comprehensive and holistic understanding of these critical biological processes.

Short biography

After completing his molecular biology studies at Bogazici University in Istanbul, Özgun Gökce became fascinated by brain function and the decline of these functions during neurodegeneration. Throughout his Ph.D. at EPFL in Lausanne, he honed his expertise in developing and characterizing neurodegeneration models, utilizing high-content imaging and transcriptomics, while embracing a data-driven research approach. As a postdoctoral fellow at Stanford University, under the guidance of Thomas Südhof and Stephen Quake, Gökce contributed to the development and application of single-cell and long sequencing technologies. In 2016, he established his independent research group at LMU Munich, focusing on hypothesis-free, bioinformatics-driven strategies to investigate brain aging. This approach led to several single-cell RNA sequencing (scRNA-seq) studies, identifying a microglial state specific to aging white matter (Safaiyan et al., 2021, Neuron) and uncovering the role of CD8 T cells in age-related white matter loss (Kaya et al., 2022, Nature Neuroscience).

At the University of Bonn, Gökce aims at developing and employing state-of-the-art technologies, such as single-cell RNA sequencing (scRNA-seq), spatial transcriptomics (ST), electron microscopy, and machine learning algorithms, to unravel the complex biological processes underlying aging and neurodegeneration.


Contact

Prof. Dr. Özgün Gökce

German Center for Neurodegenerative Diseases (DZNE)

Venusberg-Campus 1/99

D-53127 Bonn

Germany

ozguengoekce@gmail.com


Ozgun Gokce
© Ozgun Gokce / DZNE

Related news

Reckzeh News

News categories: Honors & Funding

Creating Personalized Cancer Treatments

Bonn researchers aim to improve colon cancer treatment using 3D organoids and digital twins. Funded by the Federal Ministry of Education and Research (BMBF), a collaborative project involving the University of Bonn, the company ESQlabs and the University Hospital Bonn is seeking to refine the therapy recommendations given to colon cancer patients. To this end, “ISPOT-K” is merging organoids taken from patients with the power of digital twin technology.
View entry
Prof. Dr. Valentin Schäfer

News categories: Honors & Funding

Valentin Schäfer appointed to Specialized Ethics Committee

Prof. Valentin S. Schäfer, Head of the Section of Rheumatology at the University Hospital Bonn (UKB) and researcher at the University of Bonn, has been appointed to the newly created Specialized Ethics Committee for Special Procedures by State Secretary Dr. Thomas Steffen at the Federal Ministry of Health. The committee, which is based at the Federal Institute for Drugs and Medical Devices (BfArM), will begin its work on July 1, 2025 and is responsible for the ethical evaluation of complex clinical trials.
View entry
Honorary Doctorate Sharon Lewin

News categories: Honors & Funding

Honorary Doctorate awarded to Sharon Lewin

The Faculty of Medicine at the University of Bonn has conferred an honorary doctorate on the illustrious researcher Professor Sharon Lewin. The Director of the Peter Doherty Institute for Infection and Immunity and the Cumming Global Centre for Pandemic Therapeutics, Professor Lewin is also a Laureate Professor of Medicine at the University of Melbourne in Australia and collaborates with the University Hospital Bonn. She is being recognized for her exceptional research on the international stage and her groundbreaking work in the field of HIV research in particular.
View entry

Back to the news overview